Hem Pharma, Inc. (376270) Price & Analysis

― Followers

376270 Stock Chart & Stats

₩35700.00

₩750.00(2.15%)

Jul 30, 2026

―

Day’s Range― - ―

52-Week Range₩18,000.00 - ₩97,500.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)13.46K

Market Cap

₩251.61B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.28

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding7,209,187

10 Day Avg. Volume10,065

30 Day Avg. Volume13,464

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)815

Revenue Forecast (FY)₩558.00B

376270 FAQ

What was Hem Pharma, Inc.’s price range in the past 12 months?

Hem Pharma, Inc. lowest stock price was ₩18000.00 and its highest was ₩97500.00 in the past 12 months.

What is Hem Pharma, Inc.’s market cap?

Hem Pharma, Inc.’s market cap is ₩251.61B.

When is Hem Pharma, Inc.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Hem Pharma, Inc.’s earnings last quarter?

Hem Pharma, Inc. released its earnings results on May 11, 2026. The company reported -₩580.38 earnings per share for the quarter, missing the consensus estimate of N/A by -₩580.38.

Is Hem Pharma, Inc. overvalued?

According to Wall Street analysts Hem Pharma, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hem Pharma, Inc. pay dividends?

Hem Pharma, Inc. does not currently pay dividends.

What is Hem Pharma, Inc.’s EPS estimate?

Hem Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hem Pharma, Inc. have?

Hem Pharma, Inc. has 7,209,187 shares outstanding.

What happened to Hem Pharma, Inc.’s price movement after its last earnings report?

Hem Pharma, Inc. reported an EPS of -₩580.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.863%.

Which hedge fund is a major shareholder of Hem Pharma, Inc.?

Currently, no hedge funds are holding shares in KR:376270

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology